# Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

> **NCT01485978** · PHASE3 · COMPLETED · sponsor: **Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH** · enrollment: 66 (actual)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Ramipril
- **DRUG:** placebo to ramipril
- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT01485978
- **Lead sponsor:** Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2018-09
- **Final completion:** 2019-03
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-06-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485978, "Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01485978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*